post #1 of 1
3/31/04 at 5:04pm
Thread Starter 
The FDA has released the following information.

PRODUCT
ORPHENGESIC FORTE TABLETS (Orphenadrine Citrate, Aspirin, and Caffeine Tablets) 50 mg/770 mg/60 mg, 100 and 500 tablet bottles, Rx only, NDC 49884-473-01 - 100 Tablets and NDC 49884-473-05 - 500 Tablets. Recall # D-128-4.

CODE
Lots 037407 and 037408, Expiration Date 3/2005.

RECALLING FIRM/MANUFACTURER
Par Pharmaceutical, Inc., Spring Valley, NY, by letters on March 3, 2004. Firm initiated recall is ongoing.

REASON
Subpotent; caffeine (9-month stabilty test).

VOLUME OF PRODUCT IN COMMERCE
7,648 bottles.

DISTRIBUTION
Nationwide.
Reply